HLF/HIF-2α is a key factor in retinopathy of prematurity in association with erythropoietin

EMBO Journal

Volumn 22, Issue 5, 2003, Pages 1134-1146

  Morita, Masanobu ^a   Ohneda, Osamu ^b   Yamashita, Toshiharu ^a,b   Takahashi, Satoru ^b   Suzuki, Norio ^b   Tomita, Hiroshi ^c   Kawauchi, Shimako ^b   Ema, Masatsugu ^a   Shibahara, Shigeki ^c   Udono, Tetsuo ^c   Tamai, Makoto ^c   Sogawa, Kazuhiro ^a   Yamamoto, Masayuki ^b   Fujii Kuriyama, Yoshiaki ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Erythropoietin; HLF; Neovascularization; Retinopathy; VEGF

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEOMYCIN; ANTIBODY; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CRE RECOMBINASE; HELIX LOOP HELIX PROTEIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 2, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR 2, ALPHA SUBUNIT; INTEGRASE; MESSENGER RNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIMENTIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EXON; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENE SEQUENCE; GENE TARGETING; HYPEROXIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; RETINOPATHY; WILD TYPE; ANIMAL; CYTOLOGY; DISEASE MODEL; ELECTRORETINOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; NEWBORN; NICK END LABELING; PATHOLOGY; RETINA; RETROLENTAL FIBROPLASIA; TISSUE DISTRIBUTION;

ANIMALIA; INSERTION SEQUENCES; MURINAE;

ANIMALS; ANTIBODIES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC VECTORS; HELIX-LOOP-HELIX MOTIFS; HUMANS; HYPEROXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFANT, NEWBORN; INTEGRASES; MICE; MICE, KNOCKOUT; RETINA; RETINAL NEOVASCULARIZATION; RETINOPATHY OF PREMATURITY; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIMENTIN; VIRAL PROTEINS;

EID: 0037416792     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg117     Document Type: Article

References (41)

1. Abe, T. et al. (1999) Functional analysis after auto iris pigment epithelial cell transplantation in patients with age-related macular degeneration. Tohoku J. Exp. Med., 189, 295-305.
2. Aiello, L.P., Pierce, E.A., Foley, E.D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G.L. and Smith, L.E. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl Acad. Sci. USA, 92, 10457-10461.
3. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J. and Keshet, E. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 10, 1024-1028.
4. Anagnostou, A., Lee, E.S., Kessimian, N., Levinson, R. and Steiner, M. (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc. Natl Acad. Sci. USA, 87, 5978-5982.
5. Carlini, R.G., Alonzo, E.J., Dominguez, J., Blanca, I., Weisinger, J.R., Rothstein, M. and Bellorin-Font, E. (1999) Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int., 55, 546-553.
6. Digicaylioglu, M. and Lipton, S.A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signaling cascades. Nature, 412, 641-647.
7. Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y. and Fujii-Kuriyama, Y. (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl Acad. Sci. USA, 94, 4273-4278.
8. Epstein, A.C. et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell, 107, 43-54.
9. Firth, J.D., Ebert, B.L., Pugh, C.W. and Ratcliffe, P.J. (1994) Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl Acad. Sci. USA, 91, 6496-6500.
10. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996) Activation of vascular endothelial growth factor genes transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16, 4604-4613.
11. Gerber, H.P., Condorelli, F., Park, J. and Ferrara, N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem., 272, 23659-23667.
12. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M. and Reme, C.E. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med., 8, 718-724.
13. Harada, T. et al. (1998) Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc. Natl Acad. Sci. USA, 95, 4663-4666.
14. 2homeostasis by hypoxia-inducible factor 1α. Genes Dev., 12, 149-162.
15. Jain, S., Maltepe, E., Lu, M.M., Simon, C. and Bradfield, C.A. (1998) Expression of ARNT, ARNT2, HIF-1α, HIF-2α and Ah receptor mRNAs in the developing mouse. Mech. Dev., 73, 117-123.
16. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y. and Poellinger, L. (1999) Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem., 274, 6519-6525.
17. Kappel, A., Ronicke, V., Damert, A., Flamme, I., Risau, W. and Breier, G. (1999) Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood, 93, 4284-4289.
18. Liu, Y., Cox, S.R., Morita, T. and Kourembanas, S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res., 77, 638-643.
19. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A. and Poellinger, L. (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature, 414, 550-554.
20. Moss, S.E., Klein, R. and Klein, B.E. (1994) Ten-year incidence of visual loss in a diabetic population. Ophthalmology, 101, 1061-1070.
21. Niwa, H., Araki, K., Kimura, S., Taniguchi, S., Wakasugi, S. and Yamamura, K. (1993) An efficient gene-trap method using poly A trap vectors and characterization of gene-trap events. J. Biochem., 113, 343-349.
22. Okamoto, N., Okamoto, N., Tobe, T., Hackett, S.F., Ozaki, H., Vinores, M.A., LaRochelle, W., Zack, D.J. and Campochiaro, P.A. (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am. J. Pathol., 151, 281-291.
23. Ozaki, H. et al. (1999) Hypoxia inducible factor-1α is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest. Ophthalmol. Vis. Sci., 40, 182-189.
24. Peng, J., Zhan, L., Drysdale, L. and Fong, G.H. (2000) The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc. Natl Acad. Sci. USA, 97, 8386-8391.
25. Pierce, E.A., Avery, R.L., Foley, E.D., Aiello, L.P. and Smith, L.E. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl Acad. Sci. USA, 92, 905-909.
26. Prost, M. (1988) Experimental studies on the pathogenesis of retinopathy of prematurity. Br. J. Ophthalmol., 72, 363-367.
27. Ribati, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell'Era, P., Nico, B., Roncali, L. and Dammacco, F. (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endotherial cells and stimulates neovascularization in vivo. Blood, 93, 2627-2636.
28. Ryan, H.E., Lo, J. and Johnson, R.S. (1998) HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J., 17, 3005-3015.
29. Semenza, G.L. and Wang, G.L. (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol., 12, 5447-5454.
30. Seo, M.S. et al. (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol., 154, 1743-1753.
31. Siren, A.-L. et al. (2001) Erythropoietin prevents neural apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA, 98, 4044-4049.
32. Smith, L.E., Wesolowski, E., McLellan, A., Kostyk, S.K., D'Amato, R., Sullivan, R. and D'Amore, P.A. (1994) Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci., 35, 101-111.
33. Suzuki, N., Ohneda, O., Takahashi, S., Higuchi, M., Mukai, H.Y., Nakahata, T., Imagawa, S. and Yamamoto, M. (2002) Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood, 100, 2279-2288.
34. Tian, H., McKnight, S.L. and Russell, D.W. (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev., 11, 72-82.
35. Tian, H., Hammer, R.E., Matsumoto, A.M., Russell, D.W. and McKnight, S.L. (1998) The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev., 12, 3320-3324.
36. Tobe, T., Okamoto, N., Vinores, M.A., Derevjanik, N.L., Vinores, S.A., Zack, D.J. and Campochiaro, P.A. (1998) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest. Ophthalmol. Vis. Sci., 39, 180-188.
37. Wang, G.L. and Semenza, G.L. (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA, 90, 4304-4308.
38. 2tension. Proc. Natl Acad. Sci. USA, 92, 5510-5514.
39. Wanner, R.M. et al. (2000) Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood, 96, 1558-1565.
40. Wenger, R.H. and Gassmann, M. (1997) Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem., 378, 609-616.
41. Young, P.E., Baumhueter, S. and Lasky, L.A. (1995) The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood, 85, 96-105.